nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—UGT1A9—Irinotecan—pancreatic cancer	0.249	0.353	CbGbCtD
Zileuton—CYP1A2—Dacarbazine—pancreatic cancer	0.0757	0.107	CbGbCtD
Zileuton—CYP1A2—Tamoxifen—pancreatic cancer	0.0602	0.0853	CbGbCtD
Zileuton—CYP2C9—Tamoxifen—pancreatic cancer	0.0543	0.0768	CbGbCtD
Zileuton—CYP1A2—Erlotinib—pancreatic cancer	0.0512	0.0725	CbGbCtD
Zileuton—CYP1A2—Fluorouracil—pancreatic cancer	0.0444	0.0628	CbGbCtD
Zileuton—CYP2C9—Fluorouracil—pancreatic cancer	0.04	0.0566	CbGbCtD
Zileuton—CYP3A4—Tamoxifen—pancreatic cancer	0.0316	0.0447	CbGbCtD
Zileuton—CYP3A4—Erlotinib—pancreatic cancer	0.0268	0.038	CbGbCtD
Zileuton—CYP3A4—Irinotecan—pancreatic cancer	0.0242	0.0343	CbGbCtD
Zileuton—CYP3A4—Docetaxel—pancreatic cancer	0.0178	0.0251	CbGbCtD
Zileuton—CYP3A4—Sunitinib—pancreatic cancer	0.0177	0.025	CbGbCtD
Zileuton—CYP3A4—Doxorubicin—pancreatic cancer	0.0132	0.0187	CbGbCtD
Zileuton—Pharyngolaryngeal pain—Docetaxel—pancreatic cancer	0.00193	0.0105	CcSEcCtD
Zileuton—Liver disorder—Docetaxel—pancreatic cancer	0.00191	0.0104	CcSEcCtD
Zileuton—Laryngeal pain—Docetaxel—pancreatic cancer	0.00191	0.0104	CcSEcCtD
Zileuton—Hepatotoxicity—Docetaxel—pancreatic cancer	0.00168	0.00914	CcSEcCtD
Zileuton—Abdominal pain upper—Sunitinib—pancreatic cancer	0.00151	0.00822	CcSEcCtD
Zileuton—Urinary tract infection—Tamoxifen—pancreatic cancer	0.00145	0.00787	CcSEcCtD
Zileuton—Conjunctivitis—Erlotinib—pancreatic cancer	0.00143	0.00779	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Docetaxel—pancreatic cancer	0.00143	0.00776	CcSEcCtD
Zileuton—Sinusitis—Tamoxifen—pancreatic cancer	0.0014	0.0076	CcSEcCtD
Zileuton—Hepatitis—Tamoxifen—pancreatic cancer	0.00134	0.00727	CcSEcCtD
Zileuton—Upper respiratory tract infection—Sunitinib—pancreatic cancer	0.00133	0.00723	CcSEcCtD
Zileuton—Hepatitis—Erlotinib—pancreatic cancer	0.00132	0.00719	CcSEcCtD
Zileuton—Urinary tract infection—Sunitinib—pancreatic cancer	0.00124	0.00674	CcSEcCtD
Zileuton—Hepatitis—Sunitinib—pancreatic cancer	0.00115	0.00623	CcSEcCtD
Zileuton—Flatulence—Erlotinib—pancreatic cancer	0.00114	0.00617	CcSEcCtD
Zileuton—Tiaprofenic acid—PTGS2—pancreatic cancer	0.00112	1	CrCbGaD
Zileuton—Upper respiratory tract infection—Irinotecan—pancreatic cancer	0.0011	0.00596	CcSEcCtD
Zileuton—Upper respiratory tract infection—Fluorouracil—pancreatic cancer	0.00105	0.0057	CcSEcCtD
Zileuton—Liver injury—Epirubicin—pancreatic cancer	0.00104	0.00566	CcSEcCtD
Zileuton—Jaundice—Irinotecan—pancreatic cancer	0.00103	0.00557	CcSEcCtD
Zileuton—Chest pain—Tamoxifen—pancreatic cancer	0.000992	0.00539	CcSEcCtD
Zileuton—Myalgia—Tamoxifen—pancreatic cancer	0.000992	0.00539	CcSEcCtD
Zileuton—Arthralgia—Tamoxifen—pancreatic cancer	0.000992	0.00539	CcSEcCtD
Zileuton—Flatulence—Sunitinib—pancreatic cancer	0.000984	0.00534	CcSEcCtD
Zileuton—Myalgia—Erlotinib—pancreatic cancer	0.000982	0.00533	CcSEcCtD
Zileuton—Arthralgia—Erlotinib—pancreatic cancer	0.000982	0.00533	CcSEcCtD
Zileuton—Chest pain—Erlotinib—pancreatic cancer	0.000982	0.00533	CcSEcCtD
Zileuton—Discomfort—Tamoxifen—pancreatic cancer	0.00098	0.00532	CcSEcCtD
Zileuton—Urinary tract infection—Fluorouracil—pancreatic cancer	0.00098	0.00532	CcSEcCtD
Zileuton—Conjunctivitis—Fluorouracil—pancreatic cancer	0.00098	0.00532	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Epirubicin—pancreatic cancer	0.000965	0.00524	CcSEcCtD
Zileuton—Liver injury—Doxorubicin—pancreatic cancer	0.000964	0.00524	CcSEcCtD
Zileuton—Sinusitis—Fluorouracil—pancreatic cancer	0.000946	0.00513	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Doxorubicin—pancreatic cancer	0.000892	0.00485	CcSEcCtD
Zileuton—Neck pain—Epirubicin—pancreatic cancer	0.000888	0.00482	CcSEcCtD
Zileuton—Vaginal inflammation—Epirubicin—pancreatic cancer	0.000877	0.00476	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000867	0.00471	CcSEcCtD
Zileuton—Abdominal pain upper—Docetaxel—pancreatic cancer	0.000862	0.00468	CcSEcCtD
Zileuton—Insomnia—Tamoxifen—pancreatic cancer	0.00086	0.00467	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000857	0.00466	CcSEcCtD
Zileuton—Insomnia—Erlotinib—pancreatic cancer	0.000851	0.00462	CcSEcCtD
Zileuton—Chest pain—Sunitinib—pancreatic cancer	0.00085	0.00461	CcSEcCtD
Zileuton—Myalgia—Sunitinib—pancreatic cancer	0.00085	0.00461	CcSEcCtD
Zileuton—Arthralgia—Sunitinib—pancreatic cancer	0.00085	0.00461	CcSEcCtD
Zileuton—Dyspepsia—Tamoxifen—pancreatic cancer	0.000837	0.00455	CcSEcCtD
Zileuton—Dyspepsia—Erlotinib—pancreatic cancer	0.000828	0.0045	CcSEcCtD
Zileuton—Vaginal infection—Epirubicin—pancreatic cancer	0.000828	0.0045	CcSEcCtD
Zileuton—Neck pain—Doxorubicin—pancreatic cancer	0.000821	0.00446	CcSEcCtD
Zileuton—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000821	0.00446	CcSEcCtD
Zileuton—Pain—Tamoxifen—pancreatic cancer	0.000813	0.00442	CcSEcCtD
Zileuton—Constipation—Tamoxifen—pancreatic cancer	0.000813	0.00442	CcSEcCtD
Zileuton—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000813	0.00441	CcSEcCtD
Zileuton—Vaginal inflammation—Doxorubicin—pancreatic cancer	0.000812	0.00441	CcSEcCtD
Zileuton—Flatulence—Irinotecan—pancreatic cancer	0.00081	0.0044	CcSEcCtD
Zileuton—Pain—Erlotinib—pancreatic cancer	0.000805	0.00437	CcSEcCtD
Zileuton—Constipation—Erlotinib—pancreatic cancer	0.000805	0.00437	CcSEcCtD
Zileuton—Hypertonia—Epirubicin—pancreatic cancer	0.000769	0.00417	CcSEcCtD
Zileuton—Vaginal infection—Doxorubicin—pancreatic cancer	0.000766	0.00416	CcSEcCtD
Zileuton—Ill-defined disorder—Irinotecan—pancreatic cancer	0.000763	0.00414	CcSEcCtD
Zileuton—Urticaria—Tamoxifen—pancreatic cancer	0.000756	0.0041	CcSEcCtD
Zileuton—Lymphadenopathy—Epirubicin—pancreatic cancer	0.000746	0.00405	CcSEcCtD
Zileuton—Body temperature increased—Erlotinib—pancreatic cancer	0.000744	0.00404	CcSEcCtD
Zileuton—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.000743	0.00404	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000742	0.00403	CcSEcCtD
Zileuton—Malaise—Irinotecan—pancreatic cancer	0.000742	0.00403	CcSEcCtD
Zileuton—Insomnia—Sunitinib—pancreatic cancer	0.000737	0.004	CcSEcCtD
Zileuton—Malaise—Gemcitabine—pancreatic cancer	0.000722	0.00392	CcSEcCtD
Zileuton—Dyspepsia—Sunitinib—pancreatic cancer	0.000717	0.00389	CcSEcCtD
Zileuton—Hypertonia—Doxorubicin—pancreatic cancer	0.000711	0.00386	CcSEcCtD
Zileuton—Jaundice—Docetaxel—pancreatic cancer	0.000709	0.00385	CcSEcCtD
Zileuton—Conjunctivitis—Docetaxel—pancreatic cancer	0.000707	0.00384	CcSEcCtD
Zileuton—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000703	0.00382	CcSEcCtD
Zileuton—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000701	0.00381	CcSEcCtD
Zileuton—Pain—Sunitinib—pancreatic cancer	0.000697	0.00378	CcSEcCtD
Zileuton—Constipation—Sunitinib—pancreatic cancer	0.000697	0.00378	CcSEcCtD
Zileuton—Discomfort—Irinotecan—pancreatic cancer	0.000692	0.00376	CcSEcCtD
Zileuton—Lymphadenopathy—Doxorubicin—pancreatic cancer	0.00069	0.00375	CcSEcCtD
Zileuton—Myalgia—Gemcitabine—pancreatic cancer	0.000682	0.0037	CcSEcCtD
Zileuton—Chest pain—Gemcitabine—pancreatic cancer	0.000682	0.0037	CcSEcCtD
Zileuton—Arthralgia—Gemcitabine—pancreatic cancer	0.000682	0.0037	CcSEcCtD
Zileuton—Discomfort—Gemcitabine—pancreatic cancer	0.000674	0.00366	CcSEcCtD
Zileuton—Pruritus—Tamoxifen—pancreatic cancer	0.000673	0.00365	CcSEcCtD
Zileuton—Chest pain—Fluorouracil—pancreatic cancer	0.000671	0.00364	CcSEcCtD
Zileuton—Myalgia—Fluorouracil—pancreatic cancer	0.000671	0.00364	CcSEcCtD
Zileuton—Pruritus—Erlotinib—pancreatic cancer	0.000666	0.00362	CcSEcCtD
Zileuton—Discomfort—Fluorouracil—pancreatic cancer	0.000662	0.0036	CcSEcCtD
Zileuton—Hepatitis—Docetaxel—pancreatic cancer	0.000653	0.00355	CcSEcCtD
Zileuton—Diarrhoea—Tamoxifen—pancreatic cancer	0.000651	0.00353	CcSEcCtD
Zileuton—Body temperature increased—Sunitinib—pancreatic cancer	0.000644	0.0035	CcSEcCtD
Zileuton—Diarrhoea—Erlotinib—pancreatic cancer	0.000644	0.0035	CcSEcCtD
Zileuton—Dizziness—Tamoxifen—pancreatic cancer	0.000629	0.00342	CcSEcCtD
Zileuton—Dizziness—Erlotinib—pancreatic cancer	0.000622	0.00338	CcSEcCtD
Zileuton—Insomnia—Irinotecan—pancreatic cancer	0.000607	0.0033	CcSEcCtD
Zileuton—Vomiting—Tamoxifen—pancreatic cancer	0.000605	0.00328	CcSEcCtD
Zileuton—Hypersensitivity—Sunitinib—pancreatic cancer	0.0006	0.00326	CcSEcCtD
Zileuton—Rash—Tamoxifen—pancreatic cancer	0.0006	0.00326	CcSEcCtD
Zileuton—Dermatitis—Tamoxifen—pancreatic cancer	0.000599	0.00325	CcSEcCtD
Zileuton—Vomiting—Erlotinib—pancreatic cancer	0.000598	0.00325	CcSEcCtD
Zileuton—Somnolence—Irinotecan—pancreatic cancer	0.000597	0.00324	CcSEcCtD
Zileuton—Headache—Tamoxifen—pancreatic cancer	0.000596	0.00324	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000596	0.00323	CcSEcCtD
Zileuton—Rash—Erlotinib—pancreatic cancer	0.000593	0.00322	CcSEcCtD
Zileuton—Dermatitis—Erlotinib—pancreatic cancer	0.000593	0.00322	CcSEcCtD
Zileuton—Insomnia—Gemcitabine—pancreatic cancer	0.000591	0.00321	CcSEcCtD
Zileuton—Dyspepsia—Irinotecan—pancreatic cancer	0.000591	0.00321	CcSEcCtD
Zileuton—Headache—Erlotinib—pancreatic cancer	0.00059	0.0032	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000586	0.00318	CcSEcCtD
Zileuton—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000582	0.00316	CcSEcCtD
Zileuton—Insomnia—Fluorouracil—pancreatic cancer	0.000581	0.00316	CcSEcCtD
Zileuton—Somnolence—Gemcitabine—pancreatic cancer	0.000581	0.00316	CcSEcCtD
Zileuton—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000579	0.00315	CcSEcCtD
Zileuton—Pruritus—Sunitinib—pancreatic cancer	0.000576	0.00313	CcSEcCtD
Zileuton—Pain—Irinotecan—pancreatic cancer	0.000574	0.00312	CcSEcCtD
Zileuton—Constipation—Irinotecan—pancreatic cancer	0.000574	0.00312	CcSEcCtD
Zileuton—Somnolence—Fluorouracil—pancreatic cancer	0.000571	0.0031	CcSEcCtD
Zileuton—Dyspepsia—Fluorouracil—pancreatic cancer	0.000566	0.00307	CcSEcCtD
Zileuton—Nausea—Tamoxifen—pancreatic cancer	0.000565	0.00307	CcSEcCtD
Zileuton—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000564	0.00306	CcSEcCtD
Zileuton—Constipation—Gemcitabine—pancreatic cancer	0.000559	0.00304	CcSEcCtD
Zileuton—Pain—Gemcitabine—pancreatic cancer	0.000559	0.00304	CcSEcCtD
Zileuton—Nausea—Erlotinib—pancreatic cancer	0.000559	0.00304	CcSEcCtD
Zileuton—Diarrhoea—Sunitinib—pancreatic cancer	0.000557	0.00303	CcSEcCtD
Zileuton—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000555	0.00301	CcSEcCtD
Zileuton—Feeling abnormal—Irinotecan—pancreatic cancer	0.000553	0.003	CcSEcCtD
Zileuton—Pain—Fluorouracil—pancreatic cancer	0.00055	0.00298	CcSEcCtD
Zileuton—Dizziness—Sunitinib—pancreatic cancer	0.000539	0.00293	CcSEcCtD
Zileuton—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000539	0.00292	CcSEcCtD
Zileuton—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000538	0.00292	CcSEcCtD
Zileuton—Body temperature increased—Irinotecan—pancreatic cancer	0.000531	0.00288	CcSEcCtD
Zileuton—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00053	0.00288	CcSEcCtD
Zileuton—Vomiting—Sunitinib—pancreatic cancer	0.000518	0.00281	CcSEcCtD
Zileuton—Body temperature increased—Gemcitabine—pancreatic cancer	0.000517	0.00281	CcSEcCtD
Zileuton—Rash—Sunitinib—pancreatic cancer	0.000514	0.00279	CcSEcCtD
Zileuton—Dermatitis—Sunitinib—pancreatic cancer	0.000513	0.00279	CcSEcCtD
Zileuton—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000511	0.00278	CcSEcCtD
Zileuton—Urticaria—Fluorouracil—pancreatic cancer	0.000511	0.00277	CcSEcCtD
Zileuton—Headache—Sunitinib—pancreatic cancer	0.00051	0.00277	CcSEcCtD
Zileuton—Body temperature increased—Fluorouracil—pancreatic cancer	0.000508	0.00276	CcSEcCtD
Zileuton—Hypersensitivity—Irinotecan—pancreatic cancer	0.000494	0.00268	CcSEcCtD
Zileuton—Arthralgia—Docetaxel—pancreatic cancer	0.000484	0.00263	CcSEcCtD
Zileuton—Chest pain—Docetaxel—pancreatic cancer	0.000484	0.00263	CcSEcCtD
Zileuton—Myalgia—Docetaxel—pancreatic cancer	0.000484	0.00263	CcSEcCtD
Zileuton—Nausea—Sunitinib—pancreatic cancer	0.000484	0.00263	CcSEcCtD
Zileuton—Jaundice—Epirubicin—pancreatic cancer	0.000478	0.0026	CcSEcCtD
Zileuton—Conjunctivitis—Epirubicin—pancreatic cancer	0.000477	0.00259	CcSEcCtD
Zileuton—Urinary tract infection—Epirubicin—pancreatic cancer	0.000477	0.00259	CcSEcCtD
Zileuton—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000474	0.00257	CcSEcCtD
Zileuton—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000473	0.00257	CcSEcCtD
Zileuton—Pruritus—Gemcitabine—pancreatic cancer	0.000463	0.00251	CcSEcCtD
Zileuton—Sinusitis—Epirubicin—pancreatic cancer	0.00046	0.0025	CcSEcCtD
Zileuton—Diarrhoea—Irinotecan—pancreatic cancer	0.000459	0.00249	CcSEcCtD
Zileuton—Pruritus—Fluorouracil—pancreatic cancer	0.000455	0.00247	CcSEcCtD
Zileuton—Diarrhoea—Gemcitabine—pancreatic cancer	0.000447	0.00243	CcSEcCtD
Zileuton—Dizziness—Irinotecan—pancreatic cancer	0.000444	0.00241	CcSEcCtD
Zileuton—Jaundice—Doxorubicin—pancreatic cancer	0.000443	0.0024	CcSEcCtD
Zileuton—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000441	0.0024	CcSEcCtD
Zileuton—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000441	0.0024	CcSEcCtD
Zileuton—Hepatitis—Epirubicin—pancreatic cancer	0.00044	0.00239	CcSEcCtD
Zileuton—Diarrhoea—Fluorouracil—pancreatic cancer	0.00044	0.00239	CcSEcCtD
Zileuton—Vomiting—Irinotecan—pancreatic cancer	0.000427	0.00232	CcSEcCtD
Zileuton—Sinusitis—Doxorubicin—pancreatic cancer	0.000426	0.00231	CcSEcCtD
Zileuton—Dizziness—Fluorouracil—pancreatic cancer	0.000425	0.00231	CcSEcCtD
Zileuton—Rash—Irinotecan—pancreatic cancer	0.000423	0.0023	CcSEcCtD
Zileuton—Dermatitis—Irinotecan—pancreatic cancer	0.000423	0.0023	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000423	0.00229	CcSEcCtD
Zileuton—Headache—Irinotecan—pancreatic cancer	0.00042	0.00228	CcSEcCtD
Zileuton—Insomnia—Docetaxel—pancreatic cancer	0.00042	0.00228	CcSEcCtD
Zileuton—Vomiting—Gemcitabine—pancreatic cancer	0.000416	0.00226	CcSEcCtD
Zileuton—Somnolence—Docetaxel—pancreatic cancer	0.000412	0.00224	CcSEcCtD
Zileuton—Rash—Gemcitabine—pancreatic cancer	0.000412	0.00224	CcSEcCtD
Zileuton—Dermatitis—Gemcitabine—pancreatic cancer	0.000412	0.00224	CcSEcCtD
Zileuton—Headache—Gemcitabine—pancreatic cancer	0.00041	0.00222	CcSEcCtD
Zileuton—Vomiting—Fluorouracil—pancreatic cancer	0.000409	0.00222	CcSEcCtD
Zileuton—Dyspepsia—Docetaxel—pancreatic cancer	0.000408	0.00222	CcSEcCtD
Zileuton—Hepatitis—Doxorubicin—pancreatic cancer	0.000408	0.00221	CcSEcCtD
Zileuton—Rash—Fluorouracil—pancreatic cancer	0.000405	0.0022	CcSEcCtD
Zileuton—Dermatitis—Fluorouracil—pancreatic cancer	0.000405	0.0022	CcSEcCtD
Zileuton—Headache—Fluorouracil—pancreatic cancer	0.000403	0.00219	CcSEcCtD
Zileuton—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000401	0.00217	CcSEcCtD
Zileuton—Nausea—Irinotecan—pancreatic cancer	0.000399	0.00216	CcSEcCtD
Zileuton—Pain—Docetaxel—pancreatic cancer	0.000397	0.00215	CcSEcCtD
Zileuton—Constipation—Docetaxel—pancreatic cancer	0.000397	0.00215	CcSEcCtD
Zileuton—Nausea—Gemcitabine—pancreatic cancer	0.000388	0.00211	CcSEcCtD
Zileuton—Feeling abnormal—Docetaxel—pancreatic cancer	0.000382	0.00208	CcSEcCtD
Zileuton—Nausea—Fluorouracil—pancreatic cancer	0.000382	0.00207	CcSEcCtD
Zileuton—Flatulence—Epirubicin—pancreatic cancer	0.000378	0.00205	CcSEcCtD
Zileuton—Tension—Epirubicin—pancreatic cancer	0.000376	0.00204	CcSEcCtD
Zileuton—Nervousness—Epirubicin—pancreatic cancer	0.000372	0.00202	CcSEcCtD
Zileuton—Body temperature increased—Docetaxel—pancreatic cancer	0.000367	0.00199	CcSEcCtD
Zileuton—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000356	0.00193	CcSEcCtD
Zileuton—Flatulence—Doxorubicin—pancreatic cancer	0.00035	0.0019	CcSEcCtD
Zileuton—Tension—Doxorubicin—pancreatic cancer	0.000348	0.00189	CcSEcCtD
Zileuton—Malaise—Epirubicin—pancreatic cancer	0.000346	0.00188	CcSEcCtD
Zileuton—Nervousness—Doxorubicin—pancreatic cancer	0.000345	0.00187	CcSEcCtD
Zileuton—Hypersensitivity—Docetaxel—pancreatic cancer	0.000342	0.00186	CcSEcCtD
Zileuton—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000329	0.00179	CcSEcCtD
Zileuton—Pruritus—Docetaxel—pancreatic cancer	0.000328	0.00178	CcSEcCtD
Zileuton—Myalgia—Epirubicin—pancreatic cancer	0.000326	0.00177	CcSEcCtD
Zileuton—Chest pain—Epirubicin—pancreatic cancer	0.000326	0.00177	CcSEcCtD
Zileuton—Arthralgia—Epirubicin—pancreatic cancer	0.000326	0.00177	CcSEcCtD
Zileuton—Discomfort—Epirubicin—pancreatic cancer	0.000323	0.00175	CcSEcCtD
Zileuton—Malaise—Doxorubicin—pancreatic cancer	0.00032	0.00174	CcSEcCtD
Zileuton—Diarrhoea—Docetaxel—pancreatic cancer	0.000317	0.00172	CcSEcCtD
Zileuton—Dizziness—Docetaxel—pancreatic cancer	0.000307	0.00167	CcSEcCtD
Zileuton—Myalgia—Doxorubicin—pancreatic cancer	0.000302	0.00164	CcSEcCtD
Zileuton—Arthralgia—Doxorubicin—pancreatic cancer	0.000302	0.00164	CcSEcCtD
Zileuton—Chest pain—Doxorubicin—pancreatic cancer	0.000302	0.00164	CcSEcCtD
Zileuton—Discomfort—Doxorubicin—pancreatic cancer	0.000298	0.00162	CcSEcCtD
Zileuton—Vomiting—Docetaxel—pancreatic cancer	0.000295	0.0016	CcSEcCtD
Zileuton—Rash—Docetaxel—pancreatic cancer	0.000293	0.00159	CcSEcCtD
Zileuton—Dermatitis—Docetaxel—pancreatic cancer	0.000292	0.00159	CcSEcCtD
Zileuton—Headache—Docetaxel—pancreatic cancer	0.000291	0.00158	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000285	0.00155	CcSEcCtD
Zileuton—Insomnia—Epirubicin—pancreatic cancer	0.000283	0.00154	CcSEcCtD
Zileuton—Somnolence—Epirubicin—pancreatic cancer	0.000278	0.00151	CcSEcCtD
Zileuton—Nausea—Docetaxel—pancreatic cancer	0.000276	0.0015	CcSEcCtD
Zileuton—Dyspepsia—Epirubicin—pancreatic cancer	0.000275	0.0015	CcSEcCtD
Zileuton—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00027	0.00147	CcSEcCtD
Zileuton—Constipation—Epirubicin—pancreatic cancer	0.000268	0.00145	CcSEcCtD
Zileuton—Pain—Epirubicin—pancreatic cancer	0.000268	0.00145	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000264	0.00143	CcSEcCtD
Zileuton—Insomnia—Doxorubicin—pancreatic cancer	0.000262	0.00142	CcSEcCtD
Zileuton—Feeling abnormal—Epirubicin—pancreatic cancer	0.000258	0.0014	CcSEcCtD
Zileuton—Somnolence—Doxorubicin—pancreatic cancer	0.000257	0.0014	CcSEcCtD
Zileuton—Dyspepsia—Doxorubicin—pancreatic cancer	0.000255	0.00138	CcSEcCtD
Zileuton—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00025	0.00136	CcSEcCtD
Zileuton—Urticaria—Epirubicin—pancreatic cancer	0.000249	0.00135	CcSEcCtD
Zileuton—Constipation—Doxorubicin—pancreatic cancer	0.000248	0.00134	CcSEcCtD
Zileuton—Pain—Doxorubicin—pancreatic cancer	0.000248	0.00134	CcSEcCtD
Zileuton—Body temperature increased—Epirubicin—pancreatic cancer	0.000247	0.00134	CcSEcCtD
Zileuton—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000239	0.0013	CcSEcCtD
Zileuton—Hypersensitivity—Epirubicin—pancreatic cancer	0.000231	0.00125	CcSEcCtD
Zileuton—Urticaria—Doxorubicin—pancreatic cancer	0.00023	0.00125	CcSEcCtD
Zileuton—Body temperature increased—Doxorubicin—pancreatic cancer	0.000229	0.00124	CcSEcCtD
Zileuton—Pruritus—Epirubicin—pancreatic cancer	0.000221	0.0012	CcSEcCtD
Zileuton—Diarrhoea—Epirubicin—pancreatic cancer	0.000214	0.00116	CcSEcCtD
Zileuton—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000213	0.00116	CcSEcCtD
Zileuton—Dizziness—Epirubicin—pancreatic cancer	0.000207	0.00112	CcSEcCtD
Zileuton—Pruritus—Doxorubicin—pancreatic cancer	0.000205	0.00111	CcSEcCtD
Zileuton—Vomiting—Epirubicin—pancreatic cancer	0.000199	0.00108	CcSEcCtD
Zileuton—Diarrhoea—Doxorubicin—pancreatic cancer	0.000198	0.00108	CcSEcCtD
Zileuton—Rash—Epirubicin—pancreatic cancer	0.000197	0.00107	CcSEcCtD
Zileuton—Dermatitis—Epirubicin—pancreatic cancer	0.000197	0.00107	CcSEcCtD
Zileuton—Headache—Epirubicin—pancreatic cancer	0.000196	0.00106	CcSEcCtD
Zileuton—Dizziness—Doxorubicin—pancreatic cancer	0.000191	0.00104	CcSEcCtD
Zileuton—Nausea—Epirubicin—pancreatic cancer	0.000186	0.00101	CcSEcCtD
Zileuton—Vomiting—Doxorubicin—pancreatic cancer	0.000184	0.001	CcSEcCtD
Zileuton—Rash—Doxorubicin—pancreatic cancer	0.000183	0.000991	CcSEcCtD
Zileuton—Dermatitis—Doxorubicin—pancreatic cancer	0.000182	0.00099	CcSEcCtD
Zileuton—Headache—Doxorubicin—pancreatic cancer	0.000181	0.000985	CcSEcCtD
Zileuton—Nausea—Doxorubicin—pancreatic cancer	0.000172	0.000934	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—MEN1—pancreatic cancer	0.00017	0.00157	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.000163	0.0015	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SHH—pancreatic cancer	0.000162	0.0015	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NOTCH4—pancreatic cancer	0.000161	0.00149	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IAPP—pancreatic cancer	0.00016	0.00148	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—CD44—pancreatic cancer	0.000156	0.00144	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PTHLH—pancreatic cancer	0.000154	0.00142	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PTCH1—pancreatic cancer	0.000154	0.00142	CbGpPWpGaD
Zileuton—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000154	0.00142	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000153	0.00141	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000152	0.0014	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—GCG—pancreatic cancer	0.00015	0.00138	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	0.00015	0.00138	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—TYMP—pancreatic cancer	0.000149	0.00138	CbGpPWpGaD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	0.000143	0.00132	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—STK11—pancreatic cancer	0.000141	0.0013	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SST—pancreatic cancer	0.000141	0.0013	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000139	0.00128	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—JAG1—pancreatic cancer	0.000138	0.00127	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NOTCH3—pancreatic cancer	0.000137	0.00126	CbGpPWpGaD
Zileuton—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.000135	0.00124	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.000132	0.00122	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CNR1—pancreatic cancer	0.00013	0.0012	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000126	0.00116	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—GCG—pancreatic cancer	0.000125	0.00116	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000123	0.00114	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	0.000123	0.00113	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000122	0.00113	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—TYMS—pancreatic cancer	0.000121	0.00112	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GLP1R—pancreatic cancer	0.00012	0.00111	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AGTR1—pancreatic cancer	0.00012	0.0011	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—DPYD—pancreatic cancer	0.000118	0.00109	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—STK11—pancreatic cancer	0.000118	0.00109	CbGpPWpGaD
Zileuton—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.000115	0.00106	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—SLC2A2—pancreatic cancer	0.000112	0.00104	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000111	0.00103	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000111	0.00102	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—TNF—pancreatic cancer	0.00011	0.00101	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000107	0.00099	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000106	0.000981	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PRSS1—pancreatic cancer	0.000105	0.000967	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SMAD4—pancreatic cancer	0.000103	0.000953	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000102	0.000943	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HES1—pancreatic cancer	0.000101	0.00093	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	9.94e-05	0.000918	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	9.94e-05	0.000918	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—APOE—pancreatic cancer	9.86e-05	0.00091	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.77e-05	0.000902	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	9.68e-05	0.000894	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PIK3CB—pancreatic cancer	9.65e-05	0.000891	CbGpPWpGaD
Zileuton—UGT1A9—NRF2 pathway—TGFB1—pancreatic cancer	9.63e-05	0.000889	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	9.57e-05	0.000883	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.33e-05	0.000861	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCL8—pancreatic cancer	9.27e-05	0.000856	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ARG2—pancreatic cancer	9.08e-05	0.000838	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	8.91e-05	0.000822	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CG—pancreatic cancer	8.9e-05	0.000821	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	8.89e-05	0.00082	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TERT—pancreatic cancer	8.83e-05	0.000815	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	8.72e-05	0.000804	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	8.72e-05	0.000804	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CD44—pancreatic cancer	8.7e-05	0.000803	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PPARG—pancreatic cancer	8.59e-05	0.000793	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PRSS1—pancreatic cancer	8.54e-05	0.000788	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.52e-05	0.000786	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HIF1A—pancreatic cancer	8.45e-05	0.000779	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.44e-05	0.000779	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TSC2—pancreatic cancer	8.42e-05	0.000777	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GCG—pancreatic cancer	8.34e-05	0.00077	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	8.3e-05	0.000766	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	8.3e-05	0.000766	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—APOE—pancreatic cancer	8.24e-05	0.000761	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	8.23e-05	0.00076	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—KDR—pancreatic cancer	8.08e-05	0.000745	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—TYMP—pancreatic cancer	7.94e-05	0.000733	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—STK11—pancreatic cancer	7.84e-05	0.000724	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CD—pancreatic cancer	7.82e-05	0.000722	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NFKBIA—pancreatic cancer	7.68e-05	0.000709	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NOTCH1—pancreatic cancer	7.61e-05	0.000702	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CG—pancreatic cancer	7.44e-05	0.000687	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—NRAS—pancreatic cancer	7.44e-05	0.000687	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ARG2—pancreatic cancer	7.4e-05	0.000683	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.36e-05	0.000679	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—EGF—pancreatic cancer	7.35e-05	0.000679	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	7e-05	0.000646	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CB—pancreatic cancer	6.82e-05	0.000629	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—EGFR—pancreatic cancer	6.78e-05	0.000626	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTGS2—pancreatic cancer	6.76e-05	0.000623	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—TYMS—pancreatic cancer	6.74e-05	0.000622	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.55e-05	0.000605	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CD—pancreatic cancer	6.54e-05	0.000604	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.48e-05	0.000598	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—TYMP—pancreatic cancer	6.47e-05	0.000597	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—KRAS—pancreatic cancer	6.4e-05	0.000591	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GLP1R—pancreatic cancer	6.4e-05	0.000591	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—DPYD—pancreatic cancer	6.3e-05	0.000581	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—SLC2A2—pancreatic cancer	5.97e-05	0.000551	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.91e-05	0.000546	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTEN—pancreatic cancer	5.89e-05	0.000544	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PIK3CA—pancreatic cancer	5.88e-05	0.000543	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.71e-05	0.000527	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CB—pancreatic cancer	5.7e-05	0.000526	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—APOE—pancreatic cancer	5.48e-05	0.000506	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCL8—pancreatic cancer	5.48e-05	0.000506	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—HRAS—pancreatic cancer	5.44e-05	0.000502	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.34e-05	0.000493	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—AKT1—pancreatic cancer	5.29e-05	0.000488	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CASP3—pancreatic cancer	5.24e-05	0.000484	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GLP1R—pancreatic cancer	5.22e-05	0.000481	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.2e-05	0.00048	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.19e-05	0.000479	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—DPYD—pancreatic cancer	5.13e-05	0.000474	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCND1—pancreatic cancer	5.1e-05	0.000471	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CTNNB1—pancreatic cancer	5.05e-05	0.000466	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MMP9—pancreatic cancer	4.96e-05	0.000457	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CG—pancreatic cancer	4.95e-05	0.000457	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PTEN—pancreatic cancer	4.93e-05	0.000455	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SLC2A2—pancreatic cancer	4.87e-05	0.000449	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.82e-05	0.000445	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—AKT1—pancreatic cancer	4.81e-05	0.000444	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PPARG—pancreatic cancer	4.78e-05	0.000441	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.65e-05	0.000429	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CD44—pancreatic cancer	4.63e-05	0.000427	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SRC—pancreatic cancer	4.57e-05	0.000422	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.53e-05	0.000418	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PRSS1—pancreatic cancer	4.49e-05	0.000414	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.49e-05	0.000414	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—VEGFA—pancreatic cancer	4.45e-05	0.000411	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GCG—pancreatic cancer	4.44e-05	0.000409	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—STAT3—pancreatic cancer	4.41e-05	0.000407	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NRAS—pancreatic cancer	4.4e-05	0.000406	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CD—pancreatic cancer	4.35e-05	0.000402	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.24e-05	0.000391	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—STK11—pancreatic cancer	4.17e-05	0.000385	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CA—pancreatic cancer	4.16e-05	0.000384	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MYC—pancreatic cancer	4.09e-05	0.000378	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TGFB1—pancreatic cancer	4.08e-05	0.000377	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—EGFR—pancreatic cancer	4e-05	0.00037	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.91e-05	0.000361	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ARG2—pancreatic cancer	3.89e-05	0.000359	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PRSS1—pancreatic cancer	3.84e-05	0.000354	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CB—pancreatic cancer	3.79e-05	0.00035	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—KRAS—pancreatic cancer	3.78e-05	0.000349	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CD44—pancreatic cancer	3.77e-05	0.000348	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTGS2—pancreatic cancer	3.76e-05	0.000347	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.69e-05	0.000341	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.66e-05	0.000338	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GCG—pancreatic cancer	3.62e-05	0.000334	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—TYMS—pancreatic cancer	3.59e-05	0.000331	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CA—pancreatic cancer	3.48e-05	0.000321	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—TYMP—pancreatic cancer	3.4e-05	0.000314	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—STK11—pancreatic cancer	3.4e-05	0.000314	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—AKT1—pancreatic cancer	3.4e-05	0.000313	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TP53—pancreatic cancer	3.36e-05	0.00031	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ARG2—pancreatic cancer	3.33e-05	0.000307	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTEN—pancreatic cancer	3.28e-05	0.000302	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HRAS—pancreatic cancer	3.22e-05	0.000297	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.19e-05	0.000294	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.96e-05	0.000273	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—TYMS—pancreatic cancer	2.92e-05	0.00027	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—APOE—pancreatic cancer	2.92e-05	0.000269	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—TYMP—pancreatic cancer	2.91e-05	0.000268	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AKT1—pancreatic cancer	2.84e-05	0.000262	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.81e-05	0.000259	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.76e-05	0.000255	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GLP1R—pancreatic cancer	2.74e-05	0.000253	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—DPYD—pancreatic cancer	2.7e-05	0.000249	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CG—pancreatic cancer	2.63e-05	0.000243	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ARG2—pancreatic cancer	2.57e-05	0.000237	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	2.56e-05	0.000236	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PPARG—pancreatic cancer	2.54e-05	0.000235	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.53e-05	0.000234	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.45e-05	0.000226	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.4e-05	0.000221	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—APOE—pancreatic cancer	2.38e-05	0.000219	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GLP1R—pancreatic cancer	2.34e-05	0.000216	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CD—pancreatic cancer	2.31e-05	0.000214	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CA—pancreatic cancer	2.31e-05	0.000213	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—DPYD—pancreatic cancer	2.31e-05	0.000213	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.25e-05	0.000208	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—TYMP—pancreatic cancer	2.24e-05	0.000207	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.23e-05	0.000206	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	2.19e-05	0.000202	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.16e-05	0.0002	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CG—pancreatic cancer	2.15e-05	0.000198	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.09e-05	0.000193	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PPARG—pancreatic cancer	2.07e-05	0.000191	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CB—pancreatic cancer	2.02e-05	0.000186	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTGS2—pancreatic cancer	2e-05	0.000184	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CD44—pancreatic cancer	1.98e-05	0.000183	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.94e-05	0.000179	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.92e-05	0.000178	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.9e-05	0.000176	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GCG—pancreatic cancer	1.9e-05	0.000175	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—AKT1—pancreatic cancer	1.89e-05	0.000174	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CD—pancreatic cancer	1.89e-05	0.000174	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.81e-05	0.000167	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—STK11—pancreatic cancer	1.79e-05	0.000165	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.78e-05	0.000164	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTEN—pancreatic cancer	1.74e-05	0.000161	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CD44—pancreatic cancer	1.69e-05	0.000156	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.69e-05	0.000156	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.68e-05	0.000155	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.66e-05	0.000153	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CB—pancreatic cancer	1.64e-05	0.000152	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.64e-05	0.000152	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTGS2—pancreatic cancer	1.63e-05	0.00015	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GCG—pancreatic cancer	1.62e-05	0.00015	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—TYMS—pancreatic cancer	1.54e-05	0.000142	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—STK11—pancreatic cancer	1.53e-05	0.000141	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.43e-05	0.000132	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTEN—pancreatic cancer	1.42e-05	0.000131	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.31e-05	0.000121	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CD44—pancreatic cancer	1.31e-05	0.000121	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GCG—pancreatic cancer	1.25e-05	0.000116	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—APOE—pancreatic cancer	1.25e-05	0.000115	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CA—pancreatic cancer	1.23e-05	0.000113	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.18e-05	0.000109	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—STK11—pancreatic cancer	1.18e-05	0.000109	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	1.13e-05	0.000104	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PPARG—pancreatic cancer	1.09e-05	0.0001	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—APOE—pancreatic cancer	1.07e-05	9.86e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.01e-05	9.36e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.01e-05	9.33e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AKT1—pancreatic cancer	1e-05	9.27e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CA—pancreatic cancer	1e-05	9.25e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	9.92e-06	9.15e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	9.64e-06	8.9e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PPARG—pancreatic cancer	9.31e-06	8.59e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	8.65e-06	7.98e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS2—pancreatic cancer	8.57e-06	7.91e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	8.48e-06	7.82e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—APOE—pancreatic cancer	8.25e-06	7.61e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AKT1—pancreatic cancer	8.19e-06	7.56e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTEN—pancreatic cancer	7.47e-06	6.89e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	7.44e-06	6.87e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	7.39e-06	6.82e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS2—pancreatic cancer	7.32e-06	6.76e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PPARG—pancreatic cancer	7.18e-06	6.63e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	6.54e-06	6.04e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTEN—pancreatic cancer	6.38e-06	5.89e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	5.7e-06	5.26e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS2—pancreatic cancer	5.65e-06	5.21e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	5.27e-06	4.86e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTEN—pancreatic cancer	4.93e-06	4.55e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	4.5e-06	4.16e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AKT1—pancreatic cancer	4.31e-06	3.97e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AKT1—pancreatic cancer	3.68e-06	3.4e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	3.48e-06	3.21e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.84e-06	2.62e-05	CbGpPWpGaD
